CORE
đșđŠÂ
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Phase II study of biomarker-guided neoadjuvant treatment strategy for IIIA-N2 non-small cell lung cancer based on epidermal growth factor receptor mutation status
Authors
C Xu
C Zhou
+42Â more
DB Costa
EE Schaake
ES Kim
GD Goss
GV Scagliotti
H Bai
H Lara-Guerra
Haiyan Tu
Honghong Yan
I Kappers
JA Roth
JE Chaft
Jian Su
Jinji Yang
JL Fleiss
K Takamochi
KS Albain
LA Robinson
M Wislez
NSCLC Meta-analysis Collaborative Group
Q Wang
Q Zhou
Q Zhou
Qiang Nie
Qing Zhou
R Rosell
R Rosell
Riqiang Liao
S Dong
S Yi
SJ An
Song Dong
T Hishida
T Mitsudomi
TM Chin
TS Mok
Wenzhao Zhong
Xuchao Zhang
Xuening Yang
Yi-Long Wu
YL Wu
Zhihong Chen
Publication date
Publisher
'Springer Science and Business Media LLC'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1186%2Fs13045-015-...
Last time updated on 01/04/2019